1083841

Noramco, Inc. — FEI 2522445

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 21, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wilmington, DE (United States)